While no unifying gene signature correlated with response across tumor types, consistent overlaps were observed between UC and NSCLC, highlighting common mechanisms of response to PD-L1 inhibition between tumors from different origins. The gene discussed is CD274; the disease is non-small cell lung carcinoma.